Low frequency epithelial cells in bone marrow aspirates from prostate carcinoma patients are cytogenetically aberrant

Cancer

Volumn 83, Issue 3, 1998, Pages 538-546

  Mueller, Peter ^a   Carroll, Peter ^b   Bowers, Erin ^a   Moore II, Dan ^a   Cher, Michael ^a,b   Presti, Joseph ^b   Wessman, Maija ^a   Pallavicini, Maria G ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone marrow; Chromosome abnormalities; Micrometastases; Prostate carcinoma

Indexed keywords

CYCLINE; CYTOKERATIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CHROMOSOME 1; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; EPITHELIUM CELL; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY;

AGED; AGED, 80 AND OVER; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; KERATINS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 0032147140     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980801)83:3<538::AID-CNCR23>3.0.CO;2-W     Document Type: Article

References (38)

1. Gittes RF. Carcinoma of the prostate (see comments). N Engl J Med 1991;324(4):236-45.
2. Ohori M, Wheeler TM, Scardino PT. The New American Joint Committee on Cancer and International Union Against Cancer TNM classification of prostate cancer. Clinicopathologic correlations. Cancer 1994;74:104-14.
3. Grignon DJ, Hammond EH. Report of the Prostate Cancer Working Group. Arch Pathol Lab Med 1995;119(12):1122-6.
4. Rosen MA. Impact of prostate-specific antigen screening on the natural history of prostate cancer. Urology 1995;46(6): 757-68.
5. Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 1991;9(10):1749-56.
6. Diel IJ, Kaufmann M, Goerner R, Costa SD, Kaul S, Basten G. Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis. J Clin Oncol 1992;10(10):1534-9.
7. Jauch KW, Heiss MH, Gruetzner U, Funke I, Pantel K, Riethmueller G, et al. Prognostic significance of bone marrow micrometastases in patients with gastric cancer. J Clin Oncol 1996;14:1810-7.
8. Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmuller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients, Lancet 1992; 340(8821):685-9.
9. Pantel K, Izbicki J, Passlick B, Angstwurm M, Haussinger K, Thetter O, et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 1996;347(9002):649-53.
10. Pantel K, Schlimok G, Angstwurm M, Weckermann D, Schmaus W, Gath H, et al. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 1994;3(3):165-73.
11. Litle VR, Lockett SJ, Pallavicin MG. Genotype/phenotype analyses of low frequency tumor cells using computerized image microscopy. Cytometry 1996:23:344-9.
12. Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, von Eschenbach AC, et al. Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chromosom Cancer 1994;9:19-27.
13. Baretton GB, Valina C, Vogt T, Schneiderbanger K, Diebold J, Lohrs U. Interphase cytogenetic analysis of prostatic carcinomas by use of nonisotopic in situ hybridization. Cancer Res 1994;54(16):4472-80.
14. Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB, Jensen RH. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosom Cancer 1994; 11(3):153-62.
15. Jones E, Zhu XL, Rohr LR, Stephenson RA, Brothman AR. Aneusomy of chromosomes 7 and 17 detected by FISH in prostate cancer and the effects of selection in vitro. Genes Chromosom Cancer 1994:11(3):163-70.
16. Konig JI, Teubel W, van Dongen JW, Romijn JC, Hagemeijer A, Schroder FH. Loss and gain of chromosomes 1, 18, and Y in prostate cancer. Prostate 1994;25(6):281-91.
17. 0) prostate carcinoma. Clin Cancer Res 1996;2:137-5.
18. Visakorpi T, Hyytinen E, Kallioniemi A, Isola J, Kallioniemi OP. Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Am J Pathol 1994;145(3):624-30.
19. Zitzelsberger H, Szucs S, Weier HU, Lehmann L, Braselmann H, Enders S, et al. Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections with centromere-specific DNA probes. J Pathol 1994;172(4): 325-35.
20. Qian J, Bostwick DG, Takahashi S, Borell TJ, Herath JF, Lieber MM, et al. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 1995;55(22): 5408-14.
21. Wolf I Jr., Shinohara K, Carroll PR, Narayan P. Combined role of transrectal ultrasonography. Gleason score, and prostate-specific antigen in predicting organ-confined prostate cancer. Urology 1993;42(2):131-7.
22. Schroder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M. The TNM classification of prostate cancer. Prostate Suppl 1992;4:129-38.
23. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep 1966;50:125-8.
24. Johnson GD, Nogueria JGM. A simple method of reducing the fading of immunofluorescence during microscopy. J Immunol Methods 1981;43:349-50.
25. Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 1986;83(9):2934-8.
26. McCullagh P, Neider JA. Generalized linear models. London: Chapman and Hall, 1989.
27. Chambers JM, Hastic TJ. Statistical models in S. Pacific Grove, CA: Brooks/Cole, 1992.
28. Blyth J, Colin R. Approximate binomial confidence limits. J Am Stat Assoc 1989;81:843-55.
29. Oberneder R, Riesenberg R, Kriegmair M, Bitzer U, Klammert R, Schneede P, et al. Immunocytochemical detection and phenotypic characterization of micrometastatic tumour cells in bone marrow of patients with prostate cancer. Urol Res 1994;22(1):3-8.
30. Pantel K, Aignherr C, Kollerman J, Caprano J, Riethmuller G, Kollerman MW. Immunocytochemical detection of isolated tumor cells in bone marrow of patients with untreated Stage C prostatic cancer. Eur J Cancer 1995;31A(10): 1627-32.
31. Bretton PR, Melamed MR, Fair WR, Cote RJ. Detection of occult micrometastases in the bone marrow of patients with prostate carcinoma. Prostate 1994;25(2):108-14.
32. Pantel K, Schlimok G, Braun S, Kutter D, Lindemann F, Schaller G, et al. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 1993;85(17):1419-24.
33. Bolton WE, Freeman JW, Mikulka WB, Healy CG, Schmittling RJ, Kenyon NS. Expression of proliferation-associated antigens (PCNA, p120, p 145) during the reentry of GO cells into the cell cycle. Cytometry 1994;17(1):66-74.
34. Mueller P, Weckermann D, Riethmuller G, Schlimok G. Detection of genetic alterations in micrometastatic cells in bone marrow of cancer patients by fluorescence in situ hybridization. Cancer Genet Cytogenet 1996;88(1):8-16.
35. Litle VR, Warren RS, Moore D II, Pallavicini MG. Molecular cytogenetic analysis of cytokeratin 20 (CK20)-labeled cells in primary tumors and marrow aspirates from colorectal cancer patients. Cancer 1997;79:1664-70.
36. Williams BJ, Jones E, Brothman AR. Homologous centromere association of chromosomes 9 and 17 in prostate cancer. Cancer Genet Cytogenet 1995;85(2):143-51.
37. Quijano C, Moore D II, Arthur D, Feusner J, Winter SS, Pallavicini MG. Cytogenetically aberrant cells are present in the CD34 (+) CD33-38-19-marrow compartment in children with acute lymphoblastic leukemia. Leukemia 1997;11: 1508-15.
38. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-3.